S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
The 4th Military Revolution is Happening (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Oil tanker breaks down in Egypt's Suez Canal, briefly disrupting traffic in the global waterway
The 4th Military Revolution is Happening (Ad)
With oil prices slumping, OPEC+ producers weigh more production cuts
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
The 4th Military Revolution is Happening (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Oil tanker breaks down in Egypt's Suez Canal, briefly disrupting traffic in the global waterway
The 4th Military Revolution is Happening (Ad)
With oil prices slumping, OPEC+ producers weigh more production cuts
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
The 4th Military Revolution is Happening (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Oil tanker breaks down in Egypt's Suez Canal, briefly disrupting traffic in the global waterway
The 4th Military Revolution is Happening (Ad)
With oil prices slumping, OPEC+ producers weigh more production cuts
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
The 4th Military Revolution is Happening (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Oil tanker breaks down in Egypt's Suez Canal, briefly disrupting traffic in the global waterway
The 4th Military Revolution is Happening (Ad)
With oil prices slumping, OPEC+ producers weigh more production cuts
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
NASDAQ:HCAT

Health Catalyst (HCAT) Stock Forecast, Price & News

$12.00
+0.73 (+6.48%)
(As of 06/2/2023 ET)
Compare
Today's Range
$11.41
$12.02
50-Day Range
$9.86
$13.12
52-Week Range
$6.40
$18.30
Volume
387,792 shs
Average Volume
484,443 shs
Market Capitalization
$675.12 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$15.00

Health Catalyst MarketRank™ Forecast

Analyst Rating
Hold
2.43 Rating Score
Upside/​Downside
25.0% Upside
$15.00 Price Target
Short Interest
Healthy
3.16% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.91
Upright™ Environmental Score
News Sentiment
0.90mentions of Health Catalyst in the last 14 days
Based on 3 Articles This Week
Insider Trading
Acquiring Shares
$499,820 Bought Last Quarter
Proj. Earnings Growth
Growing
From ($1.09) to ($1.02) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.43 out of 5 stars

Medical Sector

168th out of 983 stocks

Computer Programming, Data Processing, & Other Computer Related Industry

10th out of 60 stocks


HCAT stock logo

About Health Catalyst (NASDAQ:HCAT) Stock

Health Catalyst, Inc. engages in the provision of data and analytics technology and services to healthcare organizations. It operates through the Technology, and Professional Services segments. The Technology segment includes its data platform, analytics applications, and support services. The Professional Services segment combines analytics, implementation, strategic advisory, outsource, and improvement services to deliver expertise to its customers. The company was founded by Steven C. Barlow and Thomas D. Burton in 2008 and is headquartered in South Jordan, UT.

Receive HCAT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Health Catalyst and its competitors with MarketBeat's FREE daily newsletter.

HCAT Stock News Headlines

Health Catalyst, Inc. (NASDAQ:HCAT) Short Interest Update
We Called (ARWR) In Advance, Which Stocks Are Next?
Nearly 56% gains in 30 days! This bullish trend reversal was not only forecasted by A.I., but we called it 1 – 3 days in advance. If you have any money invested in the markets…even just your retirement, you’ll want to see this. Plus, it’s FREE - the training is only an hour & LIVE.
We Called (ARWR) In Advance, Which Stocks Are Next?
Nearly 56% gains in 30 days! This bullish trend reversal was not only forecasted by A.I., but we called it 1 – 3 days in advance. If you have any money invested in the markets…even just your retirement, you’ll want to see this. Plus, it’s FREE - the training is only an hour & LIVE.
Why Health Catalyst (HCAT) Shares Are Plunging Today
Health Catalyst earnings preview: what Wall Street is expecting
050923-owh-new-catalyst-pic-cm12
Keybanc Upgrades Health Catalyst (HCAT)
See More Headlines

HCAT Price History

HCAT Company Calendar

Last Earnings
5/09/2023
Today
6/03/2023
Next Earnings (Estimated)
8/03/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Computer programming, data processing, & other computer related
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:HCAT
Fax
N/A
Employees
1,200
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$15.00
High Stock Price Forecast
$18.00
Low Stock Price Forecast
$8.00
Forecasted Upside/Downside
+25.0%
Consensus Rating
Hold
Rating Score (0-4)
2.43
Research Coverage
14 Analysts

Profitability

Net Income
$-137,400,000.00
Pretax Margin
-52.76%

Debt

Sales & Book Value

Annual Sales
$276.24 million
Book Value
$7.20 per share

Miscellaneous

Free Float
55,416,000
Market Cap
$675.12 million
Optionable
Not Optionable
Beta
1.24

Key Executives

  • Daniel D. BurtonDaniel D. Burton
    Chief Executive Officer & Director
  • Anne Marie Bickmore
    Chief Operating & Product Officer
  • Bryan Hunt
    Chief Financial Officer
  • Jason Jones
    Chief Analytics & Data Science Officer
  • Melissa Welch
    Chief Medical Officer













HCAT Stock - Frequently Asked Questions

Should I buy or sell Health Catalyst stock right now?

14 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Health Catalyst in the last year. There are currently 8 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" HCAT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HCAT, but not buy additional shares or sell existing shares.
View HCAT analyst ratings
or view top-rated stocks.

What is Health Catalyst's stock price forecast for 2023?

14 brokerages have issued 1 year price objectives for Health Catalyst's shares. Their HCAT share price forecasts range from $8.00 to $18.00. On average, they anticipate the company's share price to reach $15.00 in the next twelve months. This suggests a possible upside of 25.0% from the stock's current price.
View analysts price targets for HCAT
or view top-rated stocks among Wall Street analysts.

How have HCAT shares performed in 2023?

Health Catalyst's stock was trading at $10.63 on January 1st, 2023. Since then, HCAT shares have increased by 12.9% and is now trading at $12.00.
View the best growth stocks for 2023 here
.

When is Health Catalyst's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 3rd 2023.
View our HCAT earnings forecast
.

How were Health Catalyst's earnings last quarter?

Health Catalyst, Inc. (NASDAQ:HCAT) posted its quarterly earnings data on Tuesday, May, 9th. The company reported ($0.20) earnings per share for the quarter, topping the consensus estimate of ($0.34) by $0.14. The firm earned $73.87 million during the quarter, compared to the consensus estimate of $71.16 million. Health Catalyst had a negative trailing twelve-month return on equity of 17.45% and a negative net margin of 52.53%.

What guidance has Health Catalyst issued on next quarter's earnings?

Health Catalyst issued an update on its second quarter 2023 earnings guidance on Tuesday, May, 9th. The company provided EPS guidance of for the period. The company issued revenue guidance of $70.30 million-$74.30 million, compared to the consensus revenue estimate of $72.78 million.

What is Dan Burton's approval rating as Health Catalyst's CEO?

501 employees have rated Health Catalyst Chief Executive Officer Dan Burton on Glassdoor.com. Dan Burton has an approval rating of 99% among the company's employees. This puts Dan Burton in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. 83.0% of employees surveyed would recommend working at Health Catalyst to a friend.

What other stocks do shareholders of Health Catalyst own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Health Catalyst investors own include NVIDIA (NVDA), Salesforce (CRM), Alteryx (AYX), Walt Disney (DIS), DocuSign (DOCU), Block (SQ), Slack Technologies (WORK), ServiceNow (NOW), Marvell Technology (MRVL) and PayPal (PYPL).

When did Health Catalyst IPO?

(HCAT) raised $129 million in an IPO on Thursday, July 25th 2019. The company issued 6,000,000 shares at a price of $20.00-$23.00 per share. Goldman Sachs, J.P. Morgan and William Blair acted as the underwriters for the IPO and Piper Jaffray, Evercore ISI, SVB Leerink and SunTrust Robinson Humphrey were co-managers.

What is Health Catalyst's stock symbol?

Health Catalyst trades on the NASDAQ under the ticker symbol "HCAT."

Who are Health Catalyst's major shareholders?

Health Catalyst's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (8.44%), First Light Asset Management LLC (3.52%), Daventry Group LP (2.91%), State Street Corp (2.48%), Geode Capital Management LLC (1.92%) and Balyasny Asset Management L.P. (1.87%). Insiders that own company stock include Anita Pramoda, Bryan Richard Hinton, Bryan Truman Hunt, D Fraser Bullock, Dale Sanders, Daniel D Burton, Daniel H Orenstein, Duncan Gallagher, James Patrick Jr Nelli, Jason Alger, Linda Llewelyn, Paul Horstmeier and Timothy G Ferris.
View institutional ownership trends
.

How do I buy shares of Health Catalyst?

Shares of HCAT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Health Catalyst's stock price today?

One share of HCAT stock can currently be purchased for approximately $12.00.

How much money does Health Catalyst make?

Health Catalyst (NASDAQ:HCAT) has a market capitalization of $675.12 million and generates $276.24 million in revenue each year. The company earns $-137,400,000.00 in net income (profit) each year or ($2.72) on an earnings per share basis.

How many employees does Health Catalyst have?

The company employs 1,200 workers across the globe.

How can I contact Health Catalyst?

Health Catalyst's mailing address is 3165 MILLROCK DRIVE SUITE 400, SALT LAKE CITY UT, 84121. The official website for the company is www.healthcatalyst.com. The company can be reached via phone at (801) 708-6800 or via email at ir@healthcatalyst.com.

This page (NASDAQ:HCAT) was last updated on 6/4/2023 by MarketBeat.com Staff

My Account -